David C. Benedicto Adamis Pharmaceuticals Corp (ADMP) insider trading activity
David C. Benedicto is Chief Financial Officer of Adamis Pharmaceuticals Corp. Currently has a direct ownership of 39,875 shares of ADMP, which is worth approximately $19,538. The most recent transaction as insider was on Mar 18, 2022, when has been sold 3,603 shares (Common Stock) at a price of $0.61 per share, resulting in proceeds of $2,198. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
39.9K
0%
3M change
0%
12M change
Total Value Held
$19,538
David C. Benedicto Transaction History
DCB
David C. Benedicto
Chief Financial Officer
San Diego, CA